A Phase 1 Clinical Study in Healthy Participants
Clinical trial NCT07584876 · RECRUITING
Trial details
- NCT number
- NCT07584876
- Sponsor
- Shanghai Argo Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-29
- Primary completion
- 2027-10-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.